Kevin Greenslade
Higher Scientific Officer: Paediatric Solid Tumour Biology and Therapeutics, Haemato-Oncology Group
I am an experienced researcher carrying out various in vivo models for the Chesler’s and Kranc’s groups. I am currently looking into therapeutic treatment of neuroblastoma, medulloblastoma and AML.